SCHLAGWORTE: Life Sciences
A golden era for drugs and devices
The global obesity crisis has evolved into one of the most significant healthcare
challenges of the 21st century. With over one billion people worldwide now...
‘What drives me is the vision to transform cancer care worldwide’
Theranostics, with its special subfield called radiotheranostics, is an innovative
approach that combines diagnostic imaging and targeted therapy using radionuclides to detect and treat cancer,...
Now online: The Impact Life Sciences Network
Our WHO IS WHO offers insight into the scene and its players, as well as initial guidance in your search for the right contacts...
Crowdfunding in the life sciences
Crowdfunding is a method of raising money to finance projects by collecting small contributions from a large number of people, typically via online platforms....
Patient communication is more than just bedside manners
Good healthcare has always relied on precise communication. But what happens when patients don’t understand the language spoken by the medical staff? In a...
Next-generation therapies
Ningaloo Biosystems’ technology enables the control of biological processes in living cells using light, thereby improving the productivity, quality, scalability, and reliability of pharmaceutical...
Amass sichert sich 1,4 Mio. EUR Seed-Finanzierung
Die KI-Plattform Amass hat eine Seed-Runde in Höhe von 1,4 Mio. EUR abgeschlossen. Angeführt wurde die Finanzierung von Giant Ventures, beteiligt sind zudem der...
Berlin bleibt Investitionsmagnet: Life Sciences und Fintech im Fokus
Berlin behauptet sich auch 2025 als Hotspot für Investitionen und Innovationen. Im ersten Halbjahr wurden laut der aktuellen Bilanz der Wirtschaftsfördergesellschaft Berlin Partner 668...
How big pharma companies rethink – and what start-ups can learn...
The patent cliff signifies the expiry of patent protection for major drugs, causing revenue drops as generics enter the market. Pharma companies face challenges...
Legal pathways through the valley of death
A major challenge for companies in life sciences is to live through the long years of turning innovation into clinical studies and subsequently into...
Biotech boom in Switzerland
The biotech sector is powering a strong first half year for the Swiss venture capital market. With CHF 705 million in invested capital, the...
Europe invests billions – but where are the scaled start-ups?
European countries, especially Germany, invest billions annually in basic and translational research. The scientific quality is high, the researchers are world-class, and the infrastructure...
German biotechnology needs a tailwind
Biotechnology is one of the most promising key industries – with the potential to achieve medical breakthroughs, establish new production processes and shape a...
Heading for clinical breakthrough backed by a broad investor base
Tubulis wants to improve the efficacy of cancer therapies by using antibody drug conjugates (ADCs). Three pipeline products are currently in clinical development. ‘We...
Europe’s shot at radiopharmaceutical leadership
The radiopharmaceutical industry is entering a new era. Driven by clinical breakthroughs, regulatory momentum, and investor confidence, this once-niche field is now positioned to...